Rebastinib
| CAS No. | 1020172-07-9 |
|---|---|
| MDL No. | MFCD19443646 |
| MF | C30H28FN7O3 |
| MW | 553.60 |
| InChI Key | WVXNSAVVKYZVOE-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
DCC-2036 is a urea derivative featuring a 3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl group on one nitrogen and a 2-fluoro-4-{[2-(methylcarbamoyl)pyridin-4-yl]oxy}phenyl group on the other. It functions as a tyrosine kinase inhibitor and belongs to the classes of quinolines, pyridinecarboxamides, pyrazoles, organofluorine compounds, and phenylureas.
| CAS No. | 1020172-07-9 |
|---|---|
| Product Name | Rebastinib |
Biological Targets
ABL1
Associated Conditions
neoplasm·breast carcinoma·chronic myelogenous leukemia
* The information provided here is compiled from public sources and is for reference only.
